EnteroMedics Company Profile (NASDAQ:ETRM)

About EnteroMedics (ETRM)

EnteroMedics logoEnteroMedics Inc. (EnteroMedics) is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company's neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve. The Company's initial product is the Maestro Rechargeable System, which uses VBLOC therapy to limit the expansion of the stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The Company's VBLOC therapy is designed to block the gastrointestinal effects of the vagus nerve by replicating a vagotomy using high-frequency, low-energy electrical impulses to intermittently interrupt naturally occurring neural impulses on the vagus nerve between the brain and the digestive system.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ETRM
  • CUSIP: 29365M20
Key Metrics:
  • Previous Close: $4.59
  • 50 Day Moving Average: $5.85
  • 200 Day Moving Average: $3.98
  • 52-Week Range: $1.75 - $69.30
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.04
  • P/E Growth: 0.00
  • Market Cap: $31.55M
  • Outstanding Shares: 6,873,000
  • Beta: 2.21
Profitability:
  • Net Margins: -3,236.52%
  • Return on Equity: -1,361.34%
  • Return on Assets: -190.05%
Debt:
  • Debt-to-Equity Ratio: 1.07%
  • Current Ratio: 1.20%
  • Quick Ratio: 0.93%

Analyst Ratings

Consensus Ratings for EnteroMedics (NASDAQ:ETRM) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $7.03 (53.16% upside)

Analysts' Ratings History for EnteroMedics (NASDAQ:ETRM)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
1/9/2017S&P Equity ResearchLower Price Target$17.19 -> $11.06N/AView Rating Details
6/9/2016Roth CapitalDowngradeBuy -> Neutral$3.00 -> $3.00N/AView Rating Details
11/10/2015Canaccord GenuityLower Price Target$37.50 -> $15.00N/AView Rating Details
7/20/2015Craig HallumLower Price TargetBuy$75.00 -> $30.00N/AView Rating Details
(Data available from 4/24/2015 forward)

Earnings

Earnings History for EnteroMedics (NASDAQ:ETRM)
Earnings by Quarter for EnteroMedics (NASDAQ:ETRM)
Earnings History by Quarter for EnteroMedics (NASDAQ:ETRM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2017        
3/7/2017Q4 2016($0.44)($2.65)$0.14 millionViewN/AView Earnings Details
11/10/2016Q3 2016($0.50)($0.17)$0.34 million$0.30 millionViewN/AView Earnings Details
8/4/2016Q216($0.75)($0.49)$0.19 million$0.28 millionViewN/AView Earnings Details
2/17/2016Q315($0.90)($0.95)$0.43 million$0.15 millionViewListenView Earnings Details
8/6/2015Q215($0.10)($0.10)$0.06 million$0.08 millionViewN/AView Earnings Details
2/18/2015Q414($0.10)($0.09)ViewN/AView Earnings Details
11/12/2014Q3 14($0.10)($0.08)ViewN/AView Earnings Details
8/7/2014Q2($0.10)($0.11)ViewListenView Earnings Details
4/30/2014Q1 14($0.10)($0.10)ViewN/AView Earnings Details
2/12/2014Q413($0.10)($0.11)ViewN/AView Earnings Details
10/31/2013Q313($0.11)($0.11)ViewN/AView Earnings Details
7/31/2013Q2 2013($0.13)($0.11)ViewN/AView Earnings Details
5/1/2013Q1 2013($0.13)($0.14)$0.10 millionViewN/AView Earnings Details
2/13/2013Q4 2012($0.14)($0.17)$0.36 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for EnteroMedics (NASDAQ:ETRM)
Current Year EPS Consensus Estimate: $-170.10 EPS
Next Year EPS Consensus Estimate: $-126.00 EPS

Dividends

Dividend History for EnteroMedics (NASDAQ:ETRM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for EnteroMedics (NASDAQ:ETRM)
Insider Ownership Percentage: 1.40%
Insider Trades by Quarter for EnteroMedics (NASDAQ:ETRM)
Institutional Ownership by Quarter for EnteroMedics (NASDAQ:ETRM)
Insider Trades by Quarter for EnteroMedics (NASDAQ:ETRM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/3/2016Peter M DelangeSVPBuy20,000$0.55$11,000.00View SEC Filing  
8/13/2015Mark B KnudsonCEOBuy303,000$0.25$75,750.00View SEC Filing  
6/19/2014Cathy FriedmanDirectorBuy11,800$1.70$20,060.00View SEC Filing  
1/8/2014Luke EvninDirectorSell556,585$2.50$1,391,462.50View SEC Filing  
2/27/2013Anthony P JanszDirectorBuy150,000$0.95$142,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for EnteroMedics (NASDAQ:ETRM)
Latest Headlines for EnteroMedics (NASDAQ:ETRM)
Source:
DateHeadline
finance.yahoo.com logoEnteroMedics' vBloc® Neurometabolic Therapy Recognized at 2017 ... - Yahoo Finance
finance.yahoo.com - April 24 at 8:27 AM
finance.yahoo.com logoEnteroMedics' vBloc® Neurometabolic Therapy Recognized at 2017 Edison Awards
finance.yahoo.com - April 24 at 8:27 AM
americanbankingnews.com logoEnteroMedics (ETRM) Given Coverage Optimism Score of 0.27
www.americanbankingnews.com - April 19 at 11:35 AM
americanbankingnews.com logo EnteroMedics Inc (ETRM) Receives Average Recommendation of "" from Brokerages
www.americanbankingnews.com - March 31 at 1:10 PM
streetinsider.com logoEnteroMedics (ETRM) Says vBloc Neurometabolic Therapy to be ... - StreetInsider.com
www.streetinsider.com - March 15 at 2:30 AM
seekingalpha.com logoEnteroMedics: A High Risk Short Opportunity - Seeking Alpha
seekingalpha.com - March 15 at 2:30 AM
finance.yahoo.com logoHere's Why EnteroMedics (ETRM) Stock Soared Today
finance.yahoo.com - March 14 at 4:24 PM
finance.yahoo.com logoENTEROMEDICS INC Financials
finance.yahoo.com - March 14 at 4:24 PM
finance.yahoo.com logoEnteroMedics' vBloc® Neurometabolic Therapy Featured on "The Doctors" TV Show
finance.yahoo.com - March 13 at 5:07 PM
biz.yahoo.com logoENTEROMEDICS INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 8 at 5:52 PM
baystreet.ca logoEnteroMedics (ETRM) Spikes Despite Q4 Loss
www.baystreet.ca - March 7 at 11:43 AM
us.rd.yahoo.com logoEnteroMedics Reports Fourth Quarter 2016 Financial Results
us.rd.yahoo.com - March 7 at 11:43 AM
biz.yahoo.com logoENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - March 7 at 11:43 AM
streetinsider.com logoEnteroMedics (ETRM) Regains Compliance With Nasdaq Listing Requirement
www.streetinsider.com - February 22 at 8:47 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating EnteroMedics Inc. for Potential Breaches …
finance.yahoo.com - February 22 at 8:47 AM
us.rd.yahoo.com logoEnteroMedics Regains Compliance With Nasdaq Listing Requirement
us.rd.yahoo.com - February 22 at 8:47 AM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating EnteroMedics Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
us.rd.yahoo.com - February 22 at 8:47 AM
biz.yahoo.com logoENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
biz.yahoo.com - February 14 at 11:04 PM
streetinsider.com logoEnteroMedics (ETRM) Announces 3-Year Data from vBloc Diabetic Patient Study Published in Journal of Diabetes and Obesity
www.streetinsider.com - February 10 at 3:42 AM
streetinsider.com logoEnteroMedics (ETRM) Announces 3-Year Data from vBloc Diabetic ... - StreetInsider.com
www.streetinsider.com - February 9 at 5:40 PM
us.rd.yahoo.com logoEnteroMedics Announces Publication of Three-Year Data from vBloc Diabetic Patient Study in Journal of Diabetes and Obesity
us.rd.yahoo.com - February 9 at 5:40 PM
us.rd.yahoo.com logo7:02 am EnteroMedics announces the publication of three-year data from the Company's VBLOC DM2 Study of vBloc Neurometabolic Therapy in obese patients with Type 2 diabetes
us.rd.yahoo.com - February 9 at 5:40 PM
biz.yahoo.com logoENTEROMEDICS INC Files SEC form 8-K, Other Events
biz.yahoo.com - February 8 at 5:35 PM
biz.yahoo.com logoENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - January 24 at 5:44 PM
finance.yahoo.com logoEnteroMedics Announces Closing of $19.0 Million Underwritten Public Offering and Full Exercise of Over-allotment Option
finance.yahoo.com - January 23 at 5:26 PM
benzinga.com logoEnteroMedics Short Squeeze Is Back In Play
www.benzinga.com - January 21 at 4:23 AM
rttnews.com logoEnteromedics Inc. (ETRM) Is Accelerating Higher In Early Trade
www.rttnews.com - January 21 at 4:23 AM
seekingalpha.com logoEnteroMedics tries to regain momentum; shares up 51%
seekingalpha.com - January 20 at 11:05 AM

Social

Frequently Asked Questions for EnteroMedics (NASDAQ:ETRM)

What is EnteroMedics' stock symbol?

EnteroMedics trades on the NASDAQ under the ticker symbol "ETRM."

When did EnteroMedics' stock split? How did EnteroMedics' stock split work?

EnteroMedics shares reverse split on Friday, January 8th 2016. The 1-15 reverse split was announced on Wednesday, December 23rd 2015. The number of shares owned by shareholders was adjusted after the market closes on Thursday, January 7th 2016. An investor that had 100 shares of EnteroMedics stock prior to the reverse split would have 7 shares after the split.

How were EnteroMedics' earnings last quarter?

EnteroMedics Inc (NASDAQ:ETRM) posted its earnings results on Tuesday, March, 7th. The company reported ($2.65) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.44) by $2.21. The business earned $0.14 million during the quarter. EnteroMedics had a negative net margin of 3,236.52% and a negative return on equity of 1,361.34%.

When will EnteroMedics make its next earnings announcement?

EnteroMedics is scheduled to release their next quarterly earnings announcement on Wednesday, May, 3rd 2017.

Where is EnteroMedics' stock going? Where will EnteroMedics' stock price be in 2017?

1 equities research analysts have issued 12-month price objectives for EnteroMedics' shares. Their predictions range from $3.00 to $11.06. On average, they anticipate EnteroMedics' share price to reach $7.03 in the next twelve months.

How do I buy EnteroMedics stock?

Shares of EnteroMedics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of EnteroMedics stock cost?

One share of EnteroMedics stock can currently be purchased for approximately $4.59.

EnteroMedics (ETRM) Chart for Monday, April, 24, 2017

This page was last updated on 4/24/2017 by MarketBeat.com Staff